Open AccessThe Use of Levomepromazine, a.k.a. Methotrimeprazine, a.k.a. Nozinan, in Child and Adolescent Psychiatry
Author(s) -
John Alan Lambe
Publication year - 2021
Publication title -
international journal of clinical psychiatry and mental health
Language(s) - English
Resource type - Journals
ISSN - 2310-8231
DOI - 10.12970/2310-8231.2021.09.07
Subject(s) - levomepromazine , tardive dyskinesia , medicine , psychiatry , child and adolescent psychiatry , medical prescription , pediatrics , pharmacology , schizophrenia (object oriented programming) , haloperidol , dopamine
Levomepromazine is rarely used in child and adolescent psychiatry. Four cases are described where extreme behavioural disturbance responded favourably and promptly to oral prescription. Two additional cases are described where ceasing levomepromazine led to early signs of what was probably tardive dyskinesia, resolving completely.